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ABSTRACT
Objectives: To estimate the excess in admissions
associated with type1 diabetes in childhood.
Design: Matched-cohort study using anonymously
linked hospital admission data.
Setting: Brecon Group Register of new cases of
childhood diabetes in Wales linked to hospital
admissions data within the Secure Anonymised
Information Linkage Databank.
Population: 1577 Welsh children (aged between 0
and 15 years) from the Brecon Group Register with
newly-diagnosed type-1 diabetes between 1999–2009
and 7800 population controls matched on age, sex,
county, and deprivation, randomly selected from the
local population.
Main outcome measures: Difference in all-cause
hospital admission rates, 30-days post-diagnosis until
31 May 2012, between participants and controls.
Results: Children with type-1 diabetes were followed
up for a total of 12 102 person years and were at
480% (incidence rate ratios, IRR 5.789, (95% CI 5.34
to 6.723), p<0.0001) increased risk of hospital
admission in comparison to matched controls.
The highest absolute excess of admission was in the
age group of 0–5 years, with a 15.4% (IRR 0.846,
(95% CI 0.744 to 0.965), p=0.0061) reduction in
hospital admissions for every 5-year increase in age
at diagnosis. A trend of increasing admission rates in
lower socioeconomic status groups was also
observed, but there was no evidence of a differential
rate of admissions between men and women when
adjusted for background risk. Those receiving
outpatient care at large centres had a 16.1% (IRR
0.839, (95% CI 0.709 to 0.990), p=0.0189) reduction
in hospital admissions compared with those treated at
small centres.
Conclusions: There is a large excess of hospital
admissions in paediatric patients with type-1 diabetes.
Rates are highest in the youngest children with low
socioeconomic status. Factors influencing higher
admission rates in smaller centres (eg, “out of hours
resources”) need to be explored with the aim of
targeting modifiable influences on admission rates.
INTRODUCTION
The incidence of type-1 diabetes (T1D) in
childhood is increasing 3–4% per annum,
more so in pre-school-aged,1 leading to
increasing demands on services. The manage-
ment of T1D in childhood is demanding due
to a complex treatment regimen. It is unsur-
prising that complications of suboptimal man-
agement, such as hypoglycaemia and
ketoacidosis occur, leading to hospitalisation.
In the UK, there is increasing emphasis on
delivering childhood diabetes services in
Strengths and limitations of this study
▪ Strengths of this study include the large, nation-
ally representative and nearly complete coverage
of paediatric patients with type-1 diabetes with a
matched control group.
▪ Further strengths include the integration of mul-
tiple registries, allowing all-cause hospital admis-
sion rates in young people with diabetes to be
investigated, and the use of multilevel Poisson
models to appropriately account for clustering
within matching sets and the population.
▪ Limitations also include the potential existence
of other covariables that predict hospital admis-
sion rates which were not included in the ana-
lysis. We do not have the ability to include
individual specific indicators of glycaemic
control such as glycated haemoglobin, or unit
specific level covariates which may explain differ-
ences in admission rates between large and
small centres.
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outpatient settings with potential loss of expertise
among ward staff. This may be a risk factor for deﬁcient
inpatient care of hypoglycaemia or diabetes in the peri-
operative period which has been identiﬁed.2
Understanding how often children with T1D are admit-
ted to hospital will inform the training requirements for
ward staff. Caring for all ages with diabetes is expensive,
costs of acute hospital care having risen dramatically
over the last decade and now account for over 12% of
all healthcare revenue in Wales.3 There are few pub-
lished data on costs of healthcare services for children
with T1D, though hospitalisation has a large impact on
these.4 None of the 14 standards in the Best Practice
Tariff for Paediatric Diabetes used in England to deﬁne
commissioning of children’s diabetes services, refer spe-
ciﬁcally to the needs of those hospitalised.5 National
audits of childhood diabetes focus mostly on glycated
haemoglobin (HbA1c) data, diabetes-related complica-
tions such as ketoacidosis and aspects of the outpatient-
based service process rather than wider inpatient care
issues including all-cause readmission rates.6
Furthermore, although adherence to guidelines for dia-
betes care can improve HbA1c and outpatient care
process measures, there is no evidence of beneﬁcial
impacts on hospitalisation.7
In Wales since 1995, the Brecon Group, a network of
healthcare professionals caring for children and young
people with diabetes normally resident in Wales, has sys-
tematically collected data on diagnosis.8 Knowledge of
inpatient service usage (frequency and risk factors) is
important to guide the development of clinical services
and minimise the burden of unnecessary admissions on
families and healthcare resources. These data may also
provide a measure of ongoing improvements in the
quality of paediatric diabetes care which may lead to
reduced rates of ketoacidosis and its associated mortality.9
The aims of this study are to compare hospital admis-
sion rates of children and young adults with T1D diag-
nosed in childhood to a matched cohort of individuals
without diabetes and explore factors inﬂuencing hos-
pital admissions rates.
METHODS
Study design, setting and source of data
Using a record-linkage study design, we conducted a
matched-cohort study of admission rates (from the
Patient Episode Database for Wales (PEDW)) in those
newly diagnosed with T1D in childhood identiﬁed from
the Brecon Group register8 and controls without dia-
betes in the Secure Anonymised Information Linkage
(SAIL) Databank held in the Health Information
Research Unit at Swansea University.10 The Brecon
Group register is intended to include all children devel-
oping T1D before their 15th birthday while living in
Wales and the completeness of ascertainment evaluated
in 2006 and 2013 by contacting all 530 General Practices
in Wales for a list of children with diabetes under their
care who would meet the inclusion criteria for the regis-
ter. A two-source capture–recapture model was used to
estimate the size of the total diabetic population for
each period11 and showed ascertainment to be 97.6%
and 98%, respectively. Each participant was matched
with ﬁve randomly selected controls based on gender,
county of residence, quintile of socioeconomic status
(SES)12 and week of birth (±2 weeks) as recorded in the
NHS Wales Administrative Register.13
Participants
Participants with T1D diagnosed aged under 15 years
from 1999 to 2009 were matched to unaffected popula-
tion controls selected from NHS administrative data
(further information on data sources in online
supplementary material).
Primary outcome and exposure
The primary outcome of interest is difference in hospital
admission rates, post 30 days from diagnosis, between
participants and controls (further deﬁnitions of admis-
sion in online supplementary material).
Potential confounders
Covariates of interest included age and year of birth,
gender, county of residence, quintiles of area level SES
(coded from 1(highest) to 5(lowest)), treatment centre
size and urban or rural habitation (using an Ofﬁce for
National Statistics deﬁnition of an urban locale as a
census Output Area with a population of over 10 000).14
Treatment centres where patients were initially diag-
nosed were deﬁned as either large (referring to three
hospitals in South Wales, each of which treated more
than 10% of Welsh children with T1D) or small.
Provenance of each covariate of interest is by case and
control status and is listed in the online supplementary
table S1.
Statistical methods
Population level characteristics of the Brecon Group
Register were described using cross tabulation of fre-
quencies of individuals in speciﬁc strata, and simple
person time incident rates (PTIR) in cases and controls,
and at different levels of the exposures of interest were
calculated.
Modelling strategy
A multilevel over dispersed Poisson model was used to
estimate the difference in rate of admissions between
children and young adults with diabetes compared to
the non-diabetic population. Results are reported as inci-
dence rate ratios (IRR), with 95% posterior probability
intervals and directional posterior probabilities.
Unadjusted models were used to investigate the crude
difference in the rate of admissions between cases and
controls. The matched-cohort design of the study was
incorporated into the analysis using a multilevel model-
ling approach.
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The effect of covariates was investigated by introduc-
tion of an interaction between the covariate of interest
and case–control indicator variable. Results from the
model interactions are reported. The effect of a covari-
ate on the difference in the rate of admissions between
cases and controls was assessed using the Deviance
Information Criterion (DIC), comparing the simple and
covariate-adjusted model and the directional posterioal
probability that the parameter is the wrong side of the
null. The effect of county was investigated by the intro-
duction of an additional higher-level random effect into
the model and models were similarly compared using
the DIC.
Signiﬁcant covariates were carried forward into more
completely adjusted models, and model simpliﬁcations
including treating SES and age at diagnosis as an
ordered categorical variable were also considered.
The use of multilevel modelling is necessary as it con-
trols for a number of design elements within the study.
Typically multilevel models are often taught with refer-
ence to administrative structures (ie, patients nested
within hospitals which are in turn nested in administra-
tive regions). The primary reason to conduct a multi-
level analysis is to allow for this structure and ensure
unbiased estimates are achieved. In this study multilevel
models were used for similar reasons. However, the ﬁrst
reason to use a multilevel model is to relax the assump-
tions of a Poisson model. In a Poisson model the mean
is constrained to be equal to the variance and therefore
like many other generalised linear models the level 1
residual variance is not estimated. However, using multi-
level models allows for a hyper-variance parameter to be
estimated, thereby directly testing the assumptions of a
Poission model and allowing for overdispersion.15 The
second reason to use a multilevel model is to correct the
sample size due to matched cohort design. The sample
size can be artiﬁcially inﬂated by selecting more control
participants for each case which will tend to lead to
spurious precision. The use of multilevel models cor-
rects this by modelling the correlation between the
control sets. The third reason to use multilevel models is
to allow for any regional correlation in patterns of treat-
ing patients which may lead to higher or lower rates of
hospital admissions. Further details of the multilevel
modelling approach are provided in online
supplementary material and introductory texts which
explain the context of multilevel modelling are
available.15
Sensitivity analysis
To explore the effect of possible missing admission data
when comparing rate of admissions to hospital, we inves-
tigated the effect of continuous residency throughout
the period of interest and residence in a border county.
Analyses were repeated and additionally restricted to
individuals continuously resident throughout the period
of interest and those not living in a border county.
Continuous residency was deﬁned as having no gaps
during the study period of greater than 30 days between
Welsh addresses and individuals living in a Welsh county
bordering England were excluded from the analysis.
All analyses were performed using MLwiN16 17 via the
runmlwin command18 in Stata V.12.1.19 The majority of
analyses were estimated using Markov Chain Monte
Carlo (MCMC) methods due to their superior perform-
ance in multilevel generalised linear models.20
Additionaly, effective sample size (ESS) is also reported
to indicate the amount of chain mixing. When posterior
chain mixing is low (less than 500) there is some doubt
in the reliability of the estimates. Results are reported as
IRR comparing cases to controls. For example, an IRR
of 1.2 would represent a 20% difference in rate of
admissions between cases and controls. Ninety ﬁve per
cent posterior intervals are interpreted as the range we
would expect the true parameter to lie within, 95% of
the time. Directional posterior probabilities are reported
as opposed to p values to avoid the commonly misheld
interpretation of a p value that it provides evidence that
the parameter is the wrong side of the null hypothesis of
no effect.21
RESULTS
Descriptive analyses
There were 855 boys and 722 girls identiﬁed with T1D
from the Brecon register with matched data in the SAIL
Databank. Individuals were well distributed across all
regions of Wales, with similar numbers of individuals
within each stratum of social economic position. Just
over one-ﬁfth of individuals had an age of onset of T1D
less than 5 years, whereas two-ﬁfths had an age of onset
greater than 10 years (table 1).
Thirty eight per cent of individuals were treated from
diagnosis at large centres, most living near the three
largest cities in South Wales. Approximately equal
numbers of individuals from urban (52%) and rural
(48%) locations were treated at small centres. However,
most of those treated at large centres lived in urban
locales (78%).
As controls were selected to have the same distribution
of covariates as cases, details are not presented.
Individuals from the Brecon cohort had a total of 12
102.4 years of follow-up with a total 6359 admissions to
hospital, representing half an admission per person per
year. On average children had 7.67 (median 7.53; IQR
5.05, 10.37) and 7.55 (median 7.46; IQR 4.88, 10.36)
years of follow-up time in patients with and without
T1D, respectively.
Crude analysis of admission rates
Simple PTIR per year of follow-up are presented in table 2.
These results illustrate that there is a large excess in admis-
sions in patients with T1D compared to population con-
trols. Similarly, the admission rate in boys with T1D is
higher in comparison to girls with T1D. A similar pattern is
also seen in population controls. There is a strong trend in
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Table 1 Demographic characteristics of individuals with type I diabetes selected from the Brecon cohort
Variable Follow-up time (years)
All cases
N=1577
Cases (Continuous
residency) Excluded
border county
N=1340
12 102.4 10 270.9
N Per cent N Per cent
Matching ratio
Cases: controls
1:1 3 (0.19) 2 (0.15)
1:2 11 (0.70) 10 (0.74)
1:3 15 (0.95) 16 (1.19)
1:4 10 (0.63) 14 (1.04)
1:5 1538 (97.53) 1298 (96.87)
Sex Male 855 (54.22) 727 (54.25)
Female 722 (45.78) 613 (45.75)
Socioeconomic status 1 302 (19.15) 237 (17.69)
2 307 (19.47) 222 (16.57)
3 310 (19.66) 282 (21.04)
4 328 (20.80) 287 (21.42)
5 330 (20.93) 312 (23.28)
Centre size Small centre 970 (61.51) 767 (57.24)
Large centre 607 (38.49) 573 (42.76)
Age@diagnosis (years) <5 374 (23.72) 320 (23.88)
5–10 600 (38.05) 505 (37.69)
>10 603 (38.24) 515 (38.43)
Urbanisation Rural 538 (34.12) 417 (31.12)
Urban 1039 (65.88) 923 (68.88)
County Blaenau Gwent 49 (3.11) 49 (3.66)
Bridgend 86 (5.45) 86 (6.42)
Caerphilly 118 (7.48) 118 (8.81)
Cardiff 133 (8.43) 133 (9.93)
Carmarthenshire 84 (5.33) 84 (6.27)
Ceredigion* 41 (2.60) 41 (3.06)
Conwy* 56 (3.55) 56 (4.18)
Denbighshire* 58 (3.68) 57 (4.25)
Flintshire*† 86 (5.45)
Gwynedd* 65 (4.12) 65 (4.85)
Isle of Anglesey 40 (2.54) 40 (2.99)
Merthyr Tydfil 30 (1.90) 30 (2.24)
Monmouthshire† 50 (3.17) (0.00)
Neath Port Talbot 78 (4.95) 77 (5.75)
Newport‡ 78 (4.95) 78 (5.82)
Pembrokeshire* 58 (3.68) 58 (4.33)
Powys† 48 (3.04)
Rhondda, Cynon, Taff 118 (7.48) 118 (8.81)
Swansea 121 (7.67) 121 (9.03)
The Vale of Glamorgan 76 (4.82) 75 (5.60)
Torfaen 54 (3.42) 54 (4.03)
Wrexham*† 50 (3.17)
Date of birth <90 257 (16.30) 214 (15.97)
90–94 496 (31.45) 417 (31.12)
95–99 535 (33.93) 466 (34.78)
00–04 236 (14.97) 197 (14.70)
>05 53 (3.36) 46 (3.43)
Residency Not continuous 247 (15.66)
Continuous 1330 (84.34)
*Exclusive small centre.
†Border county.
‡Exclusive large centre.
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increasing admission rates by area level SES in patients with
T1D with a similar patern of increase also observed in
population controls. We also observe an increase rate of
admissions in small centres in patients with T1D, whereas
the same increase is not observed in population controls.
Conversely, we also observe an increase in rate of admis-
sions in urban versus rural areas in patients with T1D,
whereas similar increases are not as evident in population
controls. We also observe a general increase in admission
rates with date of birth in patients with T1D and controls.
Association between rate of admission to hospitals
comparing cases to controls
Table 3, model 1 is a naive Poisson regression model
which suggests there is a 375% increase in young people
with diabetes’ rate of admissions to hospital compared
to controls. Using a multilevel model which allows the
matched design of the study to be introduced, the rate
of admissions was unchanged, but signiﬁcant variance
within the matching set was observed. The introduction
of the hyper-variance parameter clearly illustrates data
were overdispersed, and the assumption of the simple
Poisson model that the mean is equal to the variance
was violated. The (promoted) level 3 matched set vari-
ance parameter was stabilised, and there was a 388%
increase in the rate of admissions to hospital.
Utilising an MCMC estimator with diffuse priors, the
model was re-estimated, demonstrating a 480% increase
in rate of admission to hospital. The SE of the IRR (pre-
cision) of the estimate was decreased, the level 3 set vari-
ance increased, whereas overdispersion variance
reduced from 8.5 to 1.3, indicating model misspeciﬁca-
tion was not as serious as previously thought. Given the
dramatic differences and known problems of quasi-
Table 2 PTIR per year of follow-up of all cause
admissions to hospital in patients with type I diabetes and
population controls, stratified by the exposures of interest
Controls T1D
All 0.111 0.525
Sex
Male 0.095 0.449
Female 0.129 0.617
SES
1 0.101 0.337
2 0.109 0.479
3 0.090 0.473
4 0.119 0.608
5 0.130 0.710
Centre size
Large centre 0.114 0.486
Small centre 0.108 0.551
Age@diagnosis (years)
<5 0.103 0.605
5–10 0.104 0.483
>10 0.122 0.519
Urbanisation
Rural 0.105 0.434
Urban 0.113 0.572
Date of birth
<90 0.125 0.575
90–94 0.117 0.457
95–99 0.093 0.503
00–04 0.102 0.662
>05 0.153 0.796
Residency
Not continuous 0.127 0.541
Continuous 0.107 0.522
PTIR, person time incident rates; SES, socioeconomic status; TID,
type-1 diabetes.
Table 3 Incidence rate ratio of hospital admissions between individuals with type I diabetes compared to normal population
controls using different model specification and estimation
Variances
Model IRR (SE) (95% CI) p≤ ESS Level Variance (SE) (95% CI) ESS
Unmatched 1 4.756 (1.027) (4.600 to 4.918) 0.0001
Matched 2 4.744 (1.028) (4.582 to 4.912) 0.0001 2 1.012 (0.041) (0.931 to 1.092)
Over
dispersed
3 4.878 (1.141) (4.145 to 5.740) 0.0001 2 8.535 (0.156) (8.229 to 8.842)
3 0.025 (0.065) (−0.103 to 0.152)
MCMC over
dispersed
4 5.789 (1.075) (5.343 to 6.273) 0.0001 6551 2 1.267 (0.046) (1.180 to 1.360) 7081
DIC=22 370 3 0.109 (0.023) (0.066 to 0.157) 1647
Model 1 is a single level Poisson model comparing the rates of hospital admission between individuals with type I diabetes compared to
normal population controls estimated using quasi-likelihood approach. Model 2 is multilevel Poisson model which accounts for the matched
design using a 2 level variance component model, estimated using quasi-likelihood approach. Model 3 is a multilevel Poisson model which
accounts for the matched design and overdispersion using a 3 level variance component model, estimated using quasi likelihood. Results
from models 1 to 3 are reported using maximum quasi-likelihood IRR, asymptotic SE, 95% CIs and two-sided p values. Model 4 is the same
as model 3, except estimated using MCMC. Results are reported using the mean of the posterior distribution to indicate IRR, the SD of the
posterior chain is used to indicate the parameter SE, 95% posterior probability intervals (95% CI) represent the 2.5th and 97.5th centiles of
the posterior distribution, and directional posterior probabilities (p≤). ESS indicates the effectiveness of MCMC chain mixing. Bayesian DIC is
used to indicate model fit.
DIC, Deviance Information Criterion; ESS, effective sample size; MCMC, Markov Chain Monte; Carlo IRR, incidence rate ratio.
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likelihood estimators, the MCMC approach was used
throughout.
Interaction between T1D and covariates of interest
comparing cases to controls
Unadjusted models
Table 4 shows admission rates at different levels of cov-
ariates of interest comparing cases to controls. There
was no difference in rate of admissions between sexes
but large differences in rate of admissions between strata
of area level SES, with a general increase in admission
rates with lower area level SES. There is substantial
support for inclusion of area level SES in further models
with a reduction of the DIC by 20 points. Comparing dif-
ferences in rate of admissions between those in large
and small centres showed an 18% reduction in admis-
sion rate in large centres (p=0.009). Age at diagnosis is
inversely related to rate of admissions, with children
aged 5–10 years having a 25% reduction and children
over 10 years having a 40% reduction in admissions com-
pared to children under 5 years of age. There was a
small but not signiﬁcant increase in the admission rate
between those in urban compared to rural locations The
addition of a higher-level variance component, which
represents county of diagnosis, resulted in a 10 point
reduction in the DIC statistic, indicating that it explains
a large proportion of the variance in the rate of admis-
sions. There was a signiﬁcant difference in admission
rates observed with date of diagnosis (reduction in DIC
of 35), yet the pattern was quite heterogeneous.
Adjusted models
Including signiﬁcant variables from table 4 (ie, not sex
or urban/rural habitation) a more complex model was
ﬁtted. Table 5 shows the results of fully-adjusted models
using signiﬁcant variables explored in table 4. There has
been minor attenuation in differences across area level
SES. Similarly, association between age at diagnosis and
rate of admission is also attenuated, and the difference
across categories is more linear. The variability observed
between county has moderately reduced and differences
observed between large and small centres have reduced
by 1.5%. The largest attenuation is observed with respect
to the effect of date of diagnosis, suggesting other
factors explain the association between differential rates
of admission and date of diagnosis observed in simple
analyses.
Sensitivity analyses
Extensive sensitivity analyses were conducted including
(1) a linear speciﬁcation of area level SES in the model
presented in table 5. The linear parameteristation
resulted in an excess rate of admission of 16% per cat-
egory increase comparing patients with T1D and popula-
tions controls (IRR=1.163; 95% CI 1.108 to 1.222;
p≤0.0001). However, this resulted in an increase in DIC
of 30 points opposed to a fully categorical model, and
was rejected as potentially misleading. (2) We also
explored a categorical speciﬁcation of the effect of age
at diagnosis comparing cases to controls. Using a fully
categorical parameterisation resulted in an approxi-
mately 15% [loge(IRR)=−0.14] and 25% [loge(IRR)=
−0.28] reduction in the rate of admissions comparing
age at diagnosis between 5 and 10 year to under 5 years,
and over 10 years with under 5 years, respectively. As the
rate of reduction is linear on the loge(IRR) scale, we
opted for this simple speciﬁcation. (3) We also reﬁtted
the model in table 5 without the county level variance,
and effect sizes were very similar, yet the model DIC
increased by eight points (results not shown). (4) To
further investigate any migratory effects of individuals,
we restricted follow-up time to when individuals were
continuously resident in each county and to those who
did not live in a county bordering England. Two
hundred and thirty-seven individuals were removed from
the analysis (234 who lived in border areas, and three
who immediately departed from the area). Descriptive
statistics of the remaining participants are described in
table 1.
The results for the sensitivity analyses are presented in
online supplementary tables S2–S4. The differences
observed in patterning of social class were largely attenu-
ated, and only a small suggestion of an increase in
admission rates in lower social classes. The differences
in rate of admission by date of birth were also largely
attenuated. However, the effect of reduction in admis-
sion rate in large centres, and increased age at diagnosis
still persisted.
DISCUSSION
Meaning of the study’s findings
This matched-cohort study demonstrates there is a 480%
increase in the rate of all cause hospital admissions in
children with T1D compared to those without. This
increase represents a clear burden to families with dia-
betes and to the health system. Increased hospital admis-
sions were associated with not being in the highest area
level SES group, but also with being diagnosed in a
small centre and at a younger age. This suggests that
admission avoidance systems particularly targeted at the
youngest age group and smaller centres might be most
effective at reducing this burden.
Strengths and weaknesses in relation to other studies
An important strength of this study is the integration of
the Brecon Group Register into the SAIL Databank,
allowing all-cause admission rates in young people with
diabetes to be examined through linkage to hospital
admission records (PEDW) which ensures that all admis-
sions will have been captured regardless of coding difﬁ-
culties. The study is further strengthened by the large
size and near-complete coverage (97.6%) of those diag-
nosed with T1D in the Brecon Group Register, as shown
by a previous independent capture–recapture exercise
(see the Methods section). Furthermore, our ability to
6 Sayers A, et al. BMJ Open 2015;5:e005644. doi:10.1136/bmjopen-2014-005644
Open Access
group.bmj.com on July 20, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
match individuals from the Brecon cohort to healthy
population controls has enabled us to adjust effectively
for important confounding factors. Each young person
with T1D was compared to ﬁve controls matched for
location, week of birth and social class. The national
approach and minimal cross-border ﬂow avoids many
biases and confounding factors that affect studies based
on single clinics, or where patient ﬂow between units
may be high. Taking all these factors together, we
believe that our design allows us to have a high degree
of conﬁdence that the excess of admissions seen is
related in some way to diabetes and not to residual
confounding.
Unlike many studies, we reported all-cause admission
rates, not just metabolic consequences of poor diabetes
self-care. We view this as a strength as it represents the
total excess hospital-related healthcare costs for those
with T1D and an overall measure of inconvenience for
the patients and their families, although admittedly it
provides less information on the reasons for the excess.
Interventions aimed at improving outcomes for indivi-
duals with T1D and their families should consider all
cause admissions as well as diabetes speciﬁc admissions.
A recent systematic review reported four studies of all-
cause admissions in children with T1D.22 Our ﬁndings
are consistent with US studies23 24 which report
increased risks of hospitalisation with diabetes duration,
younger age, underinsurance, lower socioeconomic
class, presumed T1D phenotype, diagnosis at a commu-
nity hospital versus tertiary care facility and an
Table 4 Incidence rate ratio of hospital admissions between individuals with type I diabetes compared to normal population
controls at different levels of exposures of interest
Model
(DIC) Category
Parameter estimates Variances
IRR (SE) (95% CI) p≤ ESS Level Variance (SE) (95% CI) ESS
1 (22377) Sex
Male (ref) 5.619 (1.100) (5.039 to 6.258) 0.001 3075 1 – – – –
Female (ref) 1.058 (1.005) (0.905 to 1.238) 0.237 2953 2 1.260 (0.046) (1.173 to 1.354) 6287
3 0.092 (0.023) (0.048 to 0.138) 1290
2 (22350) SES
1 (ref) 4.794 (1.161) (3.973 to 5.771) 0.001 996 1 – – – –
2 1.182 (1.022) (0.916 to 1.531) 0.100 1594 2 1.269 (0.046) (1.181 to 1.363) 5185
3 1.308 (1.036) (1.013 to 1.697) 0.020 1516 3 0.077 (0.024) (0.030 to 0.124) 814
4 1.139 (1.017) (0.886 to 1.465) 0.156 1416
5 1.393 (1.043) (1.088 to 1.786) 0.004 1376
3 (22370) Centre size
Small (ref) 6.231 (1.098) (5.632 to 6.892) 0.001 3898 1 – – – –
Large 0.821 (0.984) (0.700 to 0.965) 0.009 3979 2 1.264 (0.046) (1.178 to 1.357) 7327
3 0.109 (0.023) (0.065 to 0.157) 1501
4 (22354) Age at diagnosis (years)
<5 (ref) 7.843 (1.185) (6.651 to 9.202) 0.001 1336 1 – – – –
5–10 0.742 (0.969) (0.605 to 0.908) 0.002 1745 2 1.260 (0.046) (1.174 to 1.353) 7068
10+ 0.599 (0.948) (0.490 to 0.737) 0.001 1629 3 0.104 (0.023) (0.060 to 0.150) 1396
5 (22372) Urban rural
Rural (ref) 5.523 (1.128) (4.801 to 6.336) 0.001 1766 1 – – – –
Urban 1.073 (1.006) (0.907 to 1.277) 0.206 1760 2 1.267 (0.047) (1.178 to 1.361) 6460
3 0.108 (0.024) (0.062 to 0.157) 1413
6 (22359) Re county
Case 5.785 (1.075) (5.338 to 6.268) 0.001 7049 1 – – – –
2 1.269 (0.046) (1.182 to 1.362) 6618
3 0.091 (0.023) (0.047 to 0.139) 1163
4 0.020 (0.011) (0.007 to 0.050) 18 169
7 (22335) Date of birth
<90 (ref) 4.737 (1.152) (3.973 to 5.653) 0.001 1033 1 – – – –
90–94 0.992 (0.999) (0.795 to 1.242) 0.474 1395 2 1.265 (0.046) (1.179 to 1.359) 7334
95–99 1.452 (1.044) (1.158 to 1.821) 0.001 1445 3 0.093 (0.023) (0.051 to 0.141) 1245
00–04 1.692 (1.076) (1.288 to 2.233) 0.001 2000
>05 1.497 (1.103) (0.930 to 2.408) 0.049 6364
All models use a multilevel Poisson model. Results are reported using the mean of the posterior distribution to indicate IRR, the SD of the
posterior chain is used to indicate the parameter SE, 95% posterior probability intervals (95% CI) represent the 2.5th and 97.5th centiles of
the posterior distribution, and directional posterior probabilities (p≤). ESS indicates the effectiveness of MCMC chain mixing. Bayesian DIC is
used to indicate model fit. The reference category comparing the IRR between cases and controls is indicated, and the IRR of the exposure of
interest is represented by the interaction between the exposure of interest and case–control status. Level 2 variance indicates the
overdispersion parameter, level 3 variance indicates the matching criteria, and level 4 (model 6) variance indicates the county level variance.
DIC, Deviance Information Criterion; ESS, effective sample size; IRR, incidence rate ratio; SES, socioeconomic status.
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unemployed head of household. Importantly other
studies have shown that the hospital admissions are asso-
ciated with major complications in the longer term,25 26
and therefore understanding the mechanisms that
underpin the observed increase are important.
An increased rate of admissions in those with T1D is
unsurprising, and the increase in rate of admissions with a
younger age at diagnosis has been previously reported.
There are few studies reporting the magnitude of the
effect on all-cause admission rates in a national cohort
which account for major sources of confounding18 19 but
our ﬁndings are consistent with studies (albeit one not
population-based27 and the other a prospective
population-based study conﬁned to the ﬁrst year after diag-
nosis28) from Germany which reported a similar increase
in admission rates compared to the age-matched general
population. Mechanisms responsible for this increase in
rate may include greater anxieties of those parents, and
healthcare professionals, caring for young children due to
their ability to quickly metabolically decompensate.29
However, the implications of this ﬁnding suggest that tar-
geted interventions, which may include additional support
and education, for parents and healthcare workers, may
help mitigate the increasing incidence of admissions in
T1D preschool-aged children.1
Understanding the differential rates of admission
between large and small centres is clearly important to
ensure outcomes for patients are optimised, as there may
be signiﬁcant risks associated with not admitting patients.
Given the possible healthcare costs and implications for
families, understanding the reason for higher admission
rates in smaller units is clearly important. A limitation of
this study is the deﬁnition of large and small treatment
centre. Currently we use the centre of diagnosis as a proxy
for centre of treatment. This is imperfect, because some
participants move during the study, and a few may have
been diagnosed at a location that is not their normal place
of treatment. However, an analysis of outpatient records
over time showed that in 88% of patient-years, participants
were receiving some form of outpatient treatment in the
same unit they were diagnosed.
The disproportionate effect of lower socioeconomic
class on increased admission rates is unsurprising given
the importance of education on diabetes outcomes and
greater risks of comorbidity in disadvantaged families.30
This study provides mixed support for previous research
in that there was no consistent trend of increasing risks
with lower categories of area level SES comparing those
with and without diabetes. The heterogeneity in results
may be attributed to the crude assessment of area level
SES, differential adherence to diabetes care, or current
initiatives which attempt to reduce health inequalities.
Conversely this study did not show increased rates of
hospital admission in women, which is in contrast to
most other studies.4 22 24 25 31 The most recent National
Paediatric Diabetes Audit in the UK shows that rates of
hospital admission for diabetic ketoacidosis are generally
higher in girls, including during puberty when maximal
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admission rates in childhood occur, and that these rates
have increased over the past 5 years.32 Therefore, the
absence of a difference in the IRR of admissions
between the genders is difﬁcult to explain at ﬁrst glance.
However, when comparing our results to studies which
have performed similar analyses, it is interesting to note
the similarities.28 For example, Icks et al28 show no differ-
ence between the sexes when comparing the rate of
admissions between patients with T1D and population
matched controls (IRR 1.0; 95% CI 0.76 to 1.31).
However, when they compare the crude admission rates
within patients with TID they observe that men have a
lower rate of admissions compared to women (IRR 0.85;
95% CI 0.61 to 1.17). This pattern of results is nearly
identical to our ﬁndings and suggests that the
female-related hospital admissions in the general popu-
lation are higher than men, and therefore a sex speciﬁc
increase in rate of admission may not be isolated to
patients with T1D.
Unanswered questions and future research
We have also shown that there is an increased rate of
admission associated with diagnosis at small centres,
which is consistent with other studies.24 However, under-
standing the reasons for this increased rate of admissions
is more difﬁcult, and a number of potential mechanisms
may underpin this observation. For example, large ter-
tiary centres may have more specialist medical or nursing
staff available to resolve patient problems without need
for admission, particularly through ‘out of hours’
support, or age-speciﬁc diabetes education packages. The
increased distance between the patients’ home and hos-
pital in rural locations may reduce the threshold for
admitting patients. However, as urban or rural classiﬁca-
tion was not associated with admission rates, it appears
unlikely that distance from the treatment centre will be
the primary mechanism which will explain the higher
rates of admissions in smaller centres.
Differences in the management of T1D may also
explain the heterogeneity in admission rates. However,
the Brecon Group network8 of healthcare professionals
are dispersed across all of Wales, and the sharing of pro-
tocols and expertise is widespread, which makes it
unlikely that signiﬁcant differences exist in philosophies
(as opposed to resources) underpinning diabetes ser-
vices across the country. Furthermore, in a study focus-
ing on HbA1c, in Wales, it was shown there was no effect
of centre size on glycaemic control.33
CONCLUSIONS
In conclusion, our population-based study provides
robust evidence to date that young people with diabetes
remain at substantial increased risk of all-cause hospital-
isation. Further study is required to identify how clinical
care should be targeted to improve outcomes and reduce
healthcare-related costs, particularly in young patients,
those from disadvantaged socioeconomic backgrounds
and those being cared for in smaller centres. This is an
area of great clinical importance, as patients admitted to
hospital with diabetes aged under 30 years have a death
rate nine times that of the general population.34
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